000302030 001__ 302030
000302030 005__ 20250622021240.0
000302030 0247_ $$2doi$$a10.1186/s13014-025-02671-2
000302030 0247_ $$2pmid$$apmid:40517223
000302030 0247_ $$2pmc$$apmc:PMC12167587
000302030 0247_ $$2altmetric$$aaltmetric:178104892
000302030 037__ $$aDKFZ-2025-01221
000302030 041__ $$aEnglish
000302030 082__ $$a610
000302030 1001_ $$aDehelean, Diana-Coralia$$b0
000302030 245__ $$aEvaluating large language models as an educational tool for meningioma patients: patient and clinician perspectives.
000302030 260__ $$aLondon$$bBioMed Central$$c2025
000302030 3367_ $$2DRIVER$$aarticle
000302030 3367_ $$2DataCite$$aOutput Types/Journal article
000302030 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1750141086_24492
000302030 3367_ $$2BibTeX$$aARTICLE
000302030 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000302030 3367_ $$00$$2EndNote$$aJournal Article
000302030 520__ $$aThe study explores the potential of ChatGPT, an advanced large language model (LLM) by OpenAI, in educating patients about meningioma, a common type of brain tumor. While ChatGPT has generated significant debate regarding its utility and ethics, its growing popularity suggests that patients may increasingly use such tools for medical information. The study specifically examines how patients who have undergone radiation therapy for meningioma perceive the information generated by ChatGPT, integrating both patient feedback and clinical assessment.Eight meningioma-related questions on diagnosis, treatment options, and radiation therapy were posed to ChatGPT 4. A questionnaire with these responses and feedback items was developed to assess utility, accuracy, clarity, and alignment with patients' experiences. Nine clinicians first rated each response's relevance, correctness, and completeness on a five-point Likert scale. Subsequently, 28 patients with meningioma completed the questionnaire during their first follow-up visit (three months post-radiation therapy). Finally, the same questions were presented to three other large language models (ChatGPT 4o mini, Gemini Free, Gemini Advanced), and seven blinded clinicians rated each model's responses before selecting the most accurate, eloquent, and comprehensive overall.The study cohort included 28 meningioma patients, mostly female, with a median age of 60 years. Most patients found the information clear, accurate, and reflective of their experiences, with 60% willing to use ChatGPT for future inquiries. Clinicians rated the relevance and correctness of the information highly, although completeness was rated slightly lower, particularly for questions about specific radiation therapy details and side effects. ChatGPT 4 and its newer version ChatGPT 4o mini received the highest, nearly identical scores among the four LLMs evaluated, while Gemini Free scored the lowest in clinician assessments.ChatGPT demonstrates potential as a supplementary educational tool for meningioma patients, though some areas may require improvement, particularly in providing comprehensive information. The study highlights the potential for integrating AI in patient education, while also noting the need for clinical oversight to ensure accuracy and completeness.LMU ethics vote nr.: 23-0742.
000302030 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000302030 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000302030 650_7 $$2Other$$aChatGPT
000302030 650_7 $$2Other$$aLarge language model
000302030 650_7 $$2Other$$aMeningioma
000302030 650_7 $$2Other$$aPatient experience
000302030 650_7 $$2Other$$aRadiation therapy
000302030 650_7 $$2Other$$aStereotactic radiosurgery
000302030 650_2 $$2MeSH$$aHumans
000302030 650_2 $$2MeSH$$aMeningioma: radiotherapy
000302030 650_2 $$2MeSH$$aMeningioma: psychology
000302030 650_2 $$2MeSH$$aFemale
000302030 650_2 $$2MeSH$$aMeningeal Neoplasms: radiotherapy
000302030 650_2 $$2MeSH$$aMeningeal Neoplasms: psychology
000302030 650_2 $$2MeSH$$aMale
000302030 650_2 $$2MeSH$$aMiddle Aged
000302030 650_2 $$2MeSH$$aSurveys and Questionnaires
000302030 650_2 $$2MeSH$$aPatient Education as Topic: methods
000302030 650_2 $$2MeSH$$aAged
000302030 650_2 $$2MeSH$$aAdult
000302030 650_2 $$2MeSH$$aLanguage
000302030 650_2 $$2MeSH$$aAged, 80 and over
000302030 650_2 $$2MeSH$$aLarge Language Models
000302030 7001_ $$aMaier, Sebastian H$$b1
000302030 7001_ $$aAltay-Langguth, Alev$$b2
000302030 7001_ $$aNitschmann, Alexander$$b3
000302030 7001_ $$aSchmeling, Michael$$b4
000302030 7001_ $$0P:(DE-He78)bc38e646ac503a9cfbb96025c129189d$$aFleischmann, Daniel$$b5
000302030 7001_ $$aRogowski, Paul$$b6
000302030 7001_ $$aTrapp, Christian$$b7
000302030 7001_ $$aCorradini, Stefanie$$b8
000302030 7001_ $$0P:(DE-HGF)0$$aBelka, Claus$$b9
000302030 7001_ $$aSchönecker, Stephan$$b10
000302030 7001_ $$aMarschner, Sebastian N$$b11
000302030 773__ $$0PERI:(DE-600)2224965-5$$a10.1186/s13014-025-02671-2$$gVol. 20, no. 1, p. 101$$n1$$p101$$tRadiation oncology$$v20$$x1748-717X$$y2025
000302030 909CO $$ooai:inrepo02.dkfz.de:302030$$pVDB
000302030 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bc38e646ac503a9cfbb96025c129189d$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000302030 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000302030 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000302030 9141_ $$y2025
000302030 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bRADIAT ONCOL : 2022$$d2024-12-18
000302030 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-18
000302030 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-18
000302030 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:44:48Z
000302030 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:44:48Z
000302030 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-04-10T15:44:48Z
000302030 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-18
000302030 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-18
000302030 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-18
000302030 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-18
000302030 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-18
000302030 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-18
000302030 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-18
000302030 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-18
000302030 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-18
000302030 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-18
000302030 9201_ $$0I:(DE-He78)MU01-20160331$$kMU01$$lDKTK Koordinierungsstelle München$$x0
000302030 980__ $$ajournal
000302030 980__ $$aVDB
000302030 980__ $$aI:(DE-He78)MU01-20160331
000302030 980__ $$aUNRESTRICTED